Artificial intelligence (AI) software developer Annalise.ai has named Lakshmi Gudapakkam as CEO and Dr. Rick Abramson as chief medical officer.
Gudapakkam comes to Annalise.ai with more than 20 years of leadership experience at companies such as GE Healthcare and Philips. In the past four years, he has served as vice president and general manager for the east region at Quest Diagnostics.
A board-certified radiologist, Abramson was previously corporate vice president for the radiology service line at HCA Healthcare. Both executives will be based in the U.S. and are expected to drive the company's expansion into the U.S., according to the firm.
In March, Annalise.ai received U.S. Food and Drug Administration (FDA) clearance for its Enterprise CXR software, which is designed for use in triage and notification of pneumothorax and tension pneumothorax on chest x-rays.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
